Approval · Notice of Compliance 11017 · 2010
TICLOPIDINE: Notice of Compliance 11017
Issued February 5, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11017
- Date
- February 5, 2010
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Inhibitor of platelet function
- Canadian reference product
- TICLID (Hoffmann-La Roche Limited)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TICLOPIDINE | 02343045 | Cancelled Post Market |
Medicinal ingredients
- TICLOPIDINE HCL 250 MG per TAB